Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emma Guttman

Showing results (281-290 of 387) with videos related to

Pageof 39
Sort By:
The Journal of Allergy and Clinical Immunology|February 25, 2026
Comprehensive single-cell transcriptomic profiling of the scalp from patients with moderate-to-severe alopecia areataBenjamin D Hu, Helen He, Swaroop Bose, et al.
The British Journal of Dermatology|April 28, 2026
Preterm Birth Is Associated with Reduced Risk of Atopic Dermatitis and a Distinct Allergic Comorbidity Profile in Early ChildhoodIben Frier Ruge, Mia-Louise Nielsen, Anne Sofie Halling, et al.
Allergy|August 14, 2023
Intrapatient comparison of atopic dermatitis skin transcriptome shows differences between tape-strips and biopsiesEster Del Duca, Helen He, Ying Liu, et al.
The Journal of Allergy and Clinical Immunology|December 5, 2021
Ritlecitinib and brepocitinib demonstrate significant improvement in scalp alopecia areata biomarkersEmma Guttman-Yassky, Ana B Pavel, Aisleen Diaz, et al.
The Journal of Allergy and Clinical Immunology|January 14, 2015
Patients with atopic dermatitis have attenuated and distinct contact hypersensitivity responses to common allergens in skinJoel Correa da Rosa, Dana Malajian, Avner Shemer, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 24, 2018
Effect of short-term liver X receptor activation on epidermal barrier features in mild to moderate atopic dermatitis: A randomized controlled trialTali Czarnowicki, Anders B Dohlman, Kunal Malik, et al.
The Journal of Investigative Dermatology|December 12, 2018
A Phase 2 Randomized Trial of Apremilast in Patients with Atopic DermatitisEric L Simpson, Shinichi Imafuku, Yves Poulin, et al.
The Journal of Allergy and Clinical Immunology|December 2, 2019
Upadacitinib in adults with moderate to severe atopic dermatitis: 16-week results from a randomized, placebo-controlled trialEmma Guttman-Yassky, Diamant Thaçi, Aileen L Pangan, et al.
The Journal of Investigative Dermatology|April 14, 2022
Transcriptomic Analysis of the Major Orphan Ichthyosis Subtypes Reveals Shared Immune and Barrier SignaturesMadeline Kim, Daniela Mikhaylov, Stephanie M Rangel, et al.
Journal of the American Academy of Dermatology|February 11, 2023
Proteomic characterization of atopic dermatitis blood from infancy to adulthoodEster Del Duca, Yael Renert-Yuval, Ana B Pavel, et al.
Pageof 39

Showing results (281-290 of 387) with videos related to

Sort By:
Pageof 39
The Journal of Allergy and Clinical Immunology|February 25, 2026
Comprehensive single-cell transcriptomic profiling of the scalp from patients with moderate-to-severe alopecia areataBenjamin D Hu, Helen He, Swaroop Bose, et al.
The British Journal of Dermatology|April 28, 2026
Preterm Birth Is Associated with Reduced Risk of Atopic Dermatitis and a Distinct Allergic Comorbidity Profile in Early ChildhoodIben Frier Ruge, Mia-Louise Nielsen, Anne Sofie Halling, et al.
Allergy|August 14, 2023
Intrapatient comparison of atopic dermatitis skin transcriptome shows differences between tape-strips and biopsiesEster Del Duca, Helen He, Ying Liu, et al.
The Journal of Allergy and Clinical Immunology|December 5, 2021
Ritlecitinib and brepocitinib demonstrate significant improvement in scalp alopecia areata biomarkersEmma Guttman-Yassky, Ana B Pavel, Aisleen Diaz, et al.
The Journal of Allergy and Clinical Immunology|January 14, 2015
Patients with atopic dermatitis have attenuated and distinct contact hypersensitivity responses to common allergens in skinJoel Correa da Rosa, Dana Malajian, Avner Shemer, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 24, 2018
Effect of short-term liver X receptor activation on epidermal barrier features in mild to moderate atopic dermatitis: A randomized controlled trialTali Czarnowicki, Anders B Dohlman, Kunal Malik, et al.
The Journal of Investigative Dermatology|December 12, 2018
A Phase 2 Randomized Trial of Apremilast in Patients with Atopic DermatitisEric L Simpson, Shinichi Imafuku, Yves Poulin, et al.
The Journal of Allergy and Clinical Immunology|December 2, 2019
Upadacitinib in adults with moderate to severe atopic dermatitis: 16-week results from a randomized, placebo-controlled trialEmma Guttman-Yassky, Diamant Thaçi, Aileen L Pangan, et al.
The Journal of Investigative Dermatology|April 14, 2022
Transcriptomic Analysis of the Major Orphan Ichthyosis Subtypes Reveals Shared Immune and Barrier SignaturesMadeline Kim, Daniela Mikhaylov, Stephanie M Rangel, et al.
Journal of the American Academy of Dermatology|February 11, 2023
Proteomic characterization of atopic dermatitis blood from infancy to adulthoodEster Del Duca, Yael Renert-Yuval, Ana B Pavel, et al.
Pageof 39